Skip to main content

Using Telehealth to Regularly Report Symptoms Improved Overall Well-being for Patients with Advanced Cancer

June 9, 2022

People with advanced cancer who communicated their symptoms weekly using an electronic survey had about a one-third better physical function and over a 15% better control of their symptoms compared to those who were evaluated less frequently via in-person clinical visits, according to findings from a multi-state study conducted at 52 community cancer clinics. The … Continued

Dr. Hanna Sanoff Writes Editorial about Rectal Cancer Study

June 8, 2022

A paper published Sunday in the New England Journal of Medicine. For the small study, all 18 patients were given dostarlimab, a checkpoint inhibitor. The results were astounding. Every patient’s cancer disappeared, undetectable by physical examination, endoscopy, PET scans, or M.R.I. scans. Dr. Hanna K. Sanoff, MD, MPH, an associate professor of medicine in the … Continued

Congratulations, Carolina Care Excellence Awardees!

May 18, 2022

Every year, UNC Hospitals conducts the Press Ganey Medical Practice survey to obtain input from patients. Patients are asked if they would refer their provider’s practice to friends and family in the survey. Over the last year, 154 providers within UNC Hospitals received the highest recommendation from more than 89 percent of their patients, putting … Continued

Charlot Leads Study Finding Multi-Faceted Intervention Resulted in Timelier Lung Cancer Surgery for Black Patients.

March 9, 2022

A detailed analysis by researchers at UNC Lineberger Comprehensive Cancer Center and Greensboro Health Disparities Collaborative designed to address racial inequities in timing from diagnosis to surgery for lung cancer found that a  multi-faceted intervention resulted in timelier lung cancer surgery for Black patients. The findings appeared Feb. 14, 2022, in the Journal of Clinical … Continued

Carey Discussed Studies of HR-Positive and HER2-Negative Advanced Breast Cancer: Overall Survival by Subtype Across Three MONALEESA Studies

December 21, 2021

Lisa A. Carey, MD, FASCO, the L. Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research, Division of Oncology and Deputy Director of Clinical Sciences for the Lineberger Comprehensive Cancer Center, discusses findings from a pooled analysis of the MONALEESA-2, -3, and -7 trials. Among the findings was a consistent overall survival benefit with … Continued

Newsworthy From the Department of Medicine, Week of November 29 – December 2

December 4, 2021

UNC researchers working to learn more about omicron variant as 1st case is identified in US – Drs. Melissa Miller and David Wohl (CBS 17) Worried about omicron? COVID’s delta strain remains a bigger threat, UNC doctors say – Drs. Melissa Miller and David Wohl (Charlotte Observer) COVID-19 Mask Recommendations Open New Chapter in Cover … Continued

Hematology/Oncology Diversity and Inclusion Initiatives

October 27, 2021

UNC Lineberger Comprehensive Cancer Center Equity Council Four members of the Department of Medicine are working to bring diversity, equity and inclusion principles into critical areas of UNC Lineberger. “This is a group of 14 faculty, graduate students, and staff–and we’re in the process of identifying patients and community members–coming together to develop a system that … Continued

Breast Cancer Awareness Month–Caring for Patients, Advancing Research

October 25, 2021

Behind every photo is a story with the power to uplift and inspire. One year has made all the difference for Frances Lucas from Fayetteville, who was diagnosed with breast cancer in May 2020. And, it was something Dr. Yara Abdou said that set the tone for her journey. “She said, ‘I’m not only going … Continued

Muss Receives Three Research Grant Awards

October 1, 2021

Hyman Muss, MD, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology in the Division of Oncology, recently received three research awards. From the Breast Cancer Research Foundation (BCRF), Muss received $190,000 in funding for “p16INK4a Expression, Chemotherapy Toxicity, and Aging in Women with Breast Cancer.” There is significant variability in chemotherapy-related toxicity in women of … Continued